MedPath

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

Phase 3
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
Registration Number
NCT05971940
Lead Sponsor
Eli Lilly and Company
Brief Summary

The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control with diet and exercise alone. The study will last approximately 54 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
559
Inclusion Criteria
  • Have Type 2 Diabetes
  • Have HbA1c ≥7.0% (53 mmol/mol) to ≤9.5% (80 mmol/mol) despite diet and exercise treatment, as determined by the central laboratory at screening.
  • Are naïve to insulin therapy except for gestational diabetes or ≤14 days use for acute treatment and have not used any oral or injectable antihyperglycemic medications during the 90 days preceding screening or between screening and randomization.
  • Are of stable weight (±5%) for at least 90 days prior to screening and agree to not initiate an intensive diet or exercise program during the study with the intent of reducing body weight other than the lifestyle and/or dietary measures for diabetes treatment.
  • Have a body mass index (BMI) ≥23.0 kilogram/square meter (kg/m²) at screening.
Exclusion Criteria
  • Have Type 1 Diabetes
  • Have a history of ketoacidosis or hyperosmolar state or coma within the last 6 months prior to screening, or between screening and randomization.
  • Currently receiving or planning to receive treatment for diabetic retinopathy and/or macular edema
  • Have New York Heart Association functional classification IV congestive heart failure.
  • Have acute or chronic pancreatitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Orforglipron Dose 3OrforglipronParticipants will receive orforglipron orally.
PlaceboPlaceboParticipants will receive placebo orally.
Orforglipron Dose 1OrforglipronParticipants will receive orforglipron orally.
Orforglipron Dose 2OrforglipronParticipants will receive orforglipron orally.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in Hemoglobin A1c (HbA1c)Baseline, Week 40
Secondary Outcome Measures
NameTimeMethod
Percentage of Participants with an HbA1c target value of <7.0% (53 mmol/mol)Week 40
Percentage of Participants with an HbA1c target value of ≤6.5% (48 mmol/mol)Week 40
Change from Baseline in Fasting Serum GlucoseBaseline, Week 40
Percentage Change from Baseline in Body WeightBaseline, Week 40
Change from Baseline in Body WeightBaseline, Week 40
Change from Baseline in Daily Average 7-point Self-Monitored Blood Glucose (SMBG)Baseline, Week 40
Change from Baseline in Systolic Blood Pressure (SBP)Baseline, Week 40
Change from Baseline in Non-HDL CholesterolBaseline, Week 40
Percentage Change from Baseline in TriglyceridesBaseline, Week 40
Percentage of Participants Who Achieved Weight Loss of ≥5%Week 40
Change from Baseline in Short Form 36 Version 2 (SF-36v2) Acute Form Domain ScoresBaseline, Week 40

Trial Locations

Locations (88)

Alliance for Multispecialty Research, LLC

🇺🇸

Norman, Oklahoma, United States

Salud Cardiovascular

🇲🇽

Guadalajara, Jalisco, Mexico

BSES MG Hospital

🇮🇳

Mumbai, Maharashtra, India

PanAmerican Clinical Research - Querétaro - Avenida Antea

🇲🇽

Querétaro, Mexico

FAICIC S. de R.L. de C.V.

🇲🇽

Veracruz, Mexico

Puerto Rico Health Institute

🇵🇷

Dorado, Puerto Rico

Instituto Veracruzano en Investigación Clínica S.C.

🇲🇽

Veracruz, Mexico

Advance Medical Research Center

🇵🇷

San Juan, Puerto Rico

Velocity Clinical Research, Westlake

🇺🇸

Los Angeles, California, United States

Tekton Research - Wichita

🇺🇸

Wichita, Kansas, United States

Rophe Adult and Pediatric Medicine/SKYCRNG

🇺🇸

Union City, Georgia, United States

Ark Clinical Research

🇺🇸

Long Beach, California, United States

Velocity Clinical Research, Dallas

🇺🇸

Dallas, Texas, United States

Endocrine Ips, Pllc

🇺🇸

Houston, Texas, United States

Ellipsis Research Group - Brooklyn - 7th Street

🇺🇸

Brooklyn, New York, United States

Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair

🇺🇸

Pittsburgh, Pennsylvania, United States

Global Health Research Center, Inc.

🇺🇸

Miami Lakes, Florida, United States

The Research Center of The Upstate

🇺🇸

Greenville, South Carolina, United States

Velocity Clinical Research, Huntington Park

🇺🇸

Huntington Park, California, United States

Clinical Research Atlanta

🇺🇸

Stockbridge, Georgia, United States

Preferred Primary Care Physicians

🇺🇸

Uniontown, Pennsylvania, United States

Beijing Pinggu District Hospital

🇨🇳

Beijing, Beijing, China

Iwamoto Clinic

🇯🇵

Zentsuji, Kagawa, Japan

Shunde Hospital of Southern Medical Univesity

🇨🇳

Foshan, Guangdong, China

The Fourth Affiliated Hospital of Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic

🇯🇵

Yamato-shi, Kanagawa, Japan

Family First Medical Center

🇺🇸

Idaho Falls, Idaho, United States

Lucas Research - New Bern

🇺🇸

New Bern, North Carolina, United States

MDFirst Research, LLC

🇺🇸

Lancaster, South Carolina, United States

GMERS Medical College and General Hospital

🇮🇳

Baroda, Gujarat, India

Beijing Hospital

🇨🇳

Beijing, Beijing, China

The Corvallis Clinic, P.C.

🇺🇸

Corvallis, Oregon, United States

Steel Memorial Yahata Hospital

🇯🇵

Kitakyushu, Fukuoka, Japan

Hayashi Diabetes Internal Medicine Clinic

🇯🇵

Chigasaki, Kanagawa, Japan

Tokuyama Clinic

🇯🇵

Mihama-ku,Chiba City, Chiba, Japan

Juno Research

🇺🇸

Houston, Texas, United States

Medstar Speciality Hospital

🇮🇳

Bangalore, Karnataka, India

Luhe Hospital

🇨🇳

Beijing, Beijing, China

Abe Clinic

🇯🇵

Oita, Japan

M S Ramaiah Medical College and Hospitals

🇮🇳

Bangalore, Karnataka, India

Medical Corporation Heishinkai OCROM Clinic

🇯🇵

Suita-shi, Osaka, Japan

Affiliated Hospital of Jiangsu University

🇨🇳

Zhenjiang, Jiangsu, China

Hasegawa Medical Clinic

🇯🇵

Chitose, Hokkaido, Japan

Madras Diabetes Research Foundation

🇮🇳

Chennai, Tamil Nadu, India

Wannan Medical College Yijishan Hospital

🇨🇳

Wuhu, Anhui, China

Huizhou Municipal Central Hospital

🇨🇳

Huizhou, Guangdong, China

Nanjing First Hospital

🇨🇳

Nanjing, Jiangsu, China

Jinan Central Hospital

🇨🇳

Jinan, Shandong, China

West China Hospital of Sichuan University

🇨🇳

Cheng Du, Sichuan, China

Pudong New Area People's Hospital Shanghai

🇨🇳

Shanghai, Shanghai, China

Quality of Life Medical & Research Center

🇺🇸

Tucson, Arizona, United States

Syed Research Consultants Llc

🇺🇸

Sheffield, Alabama, United States

Epic Medical Research - Surprise

🇺🇸

Surprise, Arizona, United States

Neighborhood Healthcare Institute of Health

🇺🇸

Escondido, California, United States

University Clinical Investigators, Inc.

🇺🇸

Tustin, California, United States

Norcal Endocrinology & Internal Medicine

🇺🇸

San Ramon, California, United States

Connecticut Clinical Research - Cromwell

🇺🇸

Cromwell, Connecticut, United States

Invictus Clinical Research Group

🇺🇸

Coconut Creek, Florida, United States

Hillcrest Medical Research

🇺🇸

DeLand, Florida, United States

K2 Medical Research

🇺🇸

Maitland, Florida, United States

West Orange Endocrinology

🇺🇸

Ocoee, Florida, United States

American Health Network of Indiana, LLC - Muncie

🇺🇸

Muncie, Indiana, United States

Billings Clinic

🇺🇸

Billings, Montana, United States

Revival Research Institute

🇺🇸

Dearborn, Michigan, United States

Central New York Clinical Research

🇺🇸

Manlius, New York, United States

Monroe Biomedical Research

🇺🇸

Monroe, North Carolina, United States

Centricity Research Dublin Multispecialty

🇺🇸

Dublin, Ohio, United States

Nanyang First People's Hospital

🇨🇳

Nanyang, Henan, China

Amir A Hassan, MD, PA

🇺🇸

Houston, Texas, United States

The Second Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

The Second Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

All India Institute of Medical Sciences (AIIMS) - Nagpur

🇮🇳

Nagpur, Maharashtra, India

Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital

🇮🇳

Kolkata, West Bengal, India

MinamiAkatsukaClinic

🇯🇵

Mito, Ibaraki, Japan

Heishinkai Medical Group ToCROM Clinic

🇯🇵

Shinjuku-ku, Tokyo, Japan

Unidad de Investigaci�n Cl�nica Cardiometabolica de Occidente

🇲🇽

Guadalajara, Jalisco, Mexico

Morinaga Ueno Clinic

🇯🇵

Kumamoto, Japan

Investigacion En Salud Y Metabolismo S.C / Nutricion Clinica / Unidad de Base de Datos

🇲🇽

Chihuahua, Mexico

Grant Medical Foundation - Ruby Hall Clinic

🇮🇳

Pune, Maharashtra, India

The Institute of Medical Science, Asahi Life Foundation

🇯🇵

Chuo-ku, Tokyo, Japan

Tokyo-Eki Center-building Clinic

🇯🇵

Chuo-ku, Tokyo, Japan

Fukuwa Clinic

🇯🇵

Chuo-ku, Tokyo, Japan

Centro de Investigacion Medica de Occidente, S.C.

🇲🇽

Zapopan, Jalisco, Mexico

Kumudini Devi Diabetes Research Center

🇮🇳

Hyderabad, Telangana, India

Burke Internal Medicine and Research

🇺🇸

Burke, Virginia, United States

The Jackson Clinic

🇺🇸

Jackson, Tennessee, United States

Infinity Clinical Research - Norco

🇺🇸

Norco, California, United States

Centro de Investigacion Medica Integral

🇲🇽

Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath